Ebola Outbreak Spotlights Aethlon Medical’s (Nasdaq: $AEMD) Advanced Preparedness Technology

 

Ebola Outbreak Spotlights Aethlon Medical’s (Nasdaq: $AEMD) Advanced Preparedness Technology

 

 

 

(Investorideas.com Newswire) Investorideas.com, a leading investment platform for retail investors reports breaking Medical Tech Stock news for  Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

 

Aethlon Medical, Inc. (NASDAQ: AEMD) today announced that it is actively monitoring developments related to the current Bundibugyo Ebola virus outbreak in Democratic Republic of the Congo and Uganda and remains prepared to engage with global healthcare and regulatory authorities regarding the potential investigational use of its Hemopurifier® technology.

 

According to recent reports from the World Health Organization (“WHO”) and other public health agencies, the current outbreak has been identified as involving the Bundibugyo strain of Ebola virus, a strain for which we are not aware of any approved treatments beyond supportive care, as of the date of this release. Health authorities continue to express concern regarding cross-border transmission and the potential for broader regional spread. Public health assessments, including regarding potential cross-border transmission, are evolving and subject to change.

 

Paid News Dissemination of behalf of AEMD

Read this news, featuring AEMD in full at https://www.investorideas.com/CO/AEMD/news/2026/05211-aethlon-medical-aemd-ebola-outbreak-hemopurifier.asp

Aethlon’s Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived EVs from circulation. During the 2014 Ebola (Zaire strain) outbreak, the Hemopurifier was successfully administered to a critically ill Ugandan physician treated at Frankfurt University Hospital under emergency-use circumstances.

At the time Hemopurifier therapy was initiated, the physician was unconscious and suffering from multiple organ failure requiring mechanical ventilation, vasopressor support and continuous dialysis. Following a single 6.5-hour Hemopurifier treatment, the patient’s viral load reportedly declined from approximately 400,000 Ebola virus copies per milliliter of blood to approximately 1,000 copies per milliliter of blood. The Ebola virus subsequently became undetectable five days following treatment. Testing performed after this treatment indicated that the Hemopurifier  captured Ebola virus during therapy; quantitative estimates reported at the time, were approximately 242 million virions. The patient ultimately made recovered and returned home to Uganda.

 

That treatment data was presented at the American Society of Nephrology Annual Meeting on November 14, 2014 by Helmut Geiger, M.D., Chief of Nephrology at Goethe University, Frankfurt University Hospital.

 

In the United States, Hemopurifier therapy has previously been made available for Ebola patients through FDA expanded access emergency-use provisions applicable to life-threatening circumstances where alternative therapies may not be available. In January 2015, the U.S. Food and Drug Administration approved an Investigational Device Exemption (“IDE”) supplement that established a regulatory pathway for the potential investigational use of Hemopurifier therapy in Ebola-infected individuals in the United States, subject to applicable institutional approvals and patient protection procedures.

 

Investigational use of medical technologies such as the Hemopurifier may proceed through physician-directed emergency and compassionate-use procedures subject to applicable hospital and regulatory oversight.

 

“We believe the current Ebola outbreak reinforces the ongoing need for broad-spectrum therapeutic approaches capable of addressing viral threats where approved drug therapies or vaccines may be limited,” stated James B. Frakes, Chief Executive Officer of Aethlon Medical. “While the Hemopurifier remains investigational for Ebola treatment, the prior clinical experience on one patient in Germany demonstrated the potential for rapid viral reduction in a critically ill patient under emergency-use conditions.”

 

The Company stated that it will continue to monitor the evolving Ebola situation and will respond to questions or requests from treating clinicians.

 

About the Hemopurifier®

The Aethlon Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived EVs from circulation. It is used extracorporeally with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich surfaces found on EVs and viruses. EVs released by solid tumors are believed to play a role in metastasis and the resistance to immunotherapies and chemotherapy. Removal of enveloped viruses and extracellular vesicles has been demonstrated in both vitro studies and human subjects.

 

The Hemopurifier holds a U.S. Food and Drug Breakthrough Device for:

·         The treatment of individuals with advanced or metastatic cancer unresponsive to or intolerant of standard-of-care therapy; and

·         The treatment of life-threatening viruses not addressed with approved therapies.

 

The Hemopurifier is being developed under an open IDE for both indications.

 

About Aethlon Medical, Inc.

Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical stage medical device company headquartered in San Diego, California. Aethlon is advancing the Hemopurifier, to address unmet needs in oncology and infectious disease, using a novel platform designed to selectively remove circulation pathogenic targets from biologic fluids. For more information visit www.AethlonMedical.com and follow the company on LinkedIn.

 

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," "potentially" or similar expressions constitute forward-looking statements. Forward-looking statements in this press release  include but are not limited to statements regarding Aethlon’s active monitoring of developments related to the current Bundibugyo Ebola virus outbreak in the Democratic Republic of the Congo and Uganda; potential engagement and responsiveness to inquiries from treating clinicians and hospitals; potential interactions with global healthcare and regulatory authorities concerning potential investigational use of the Hemopurifier technology; the investigational status of the Hemopurifier for Ebola; references to prior emergency-use and FDA expanded access pathways; and the Company’s development plans, regulatory pathway, and potential applications of the Hemopurifier, including its Breakthrough Device designation and ongoing development under an (IDE for oncology and life‑threatening viral indications. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such include, without limitation, the need for and availability of physician-directed emergency or compassionate-use procedures; the requirement for and timing of applicable hospital and regulatory oversight, including institutional approvals and patient protection procedures; uncertainties inherent in investigational use of medical technologies; device performance, deficiencies, or immediate complications; clinical operations, logistics, and timing (including enrollment and access to eligible patients); the status of alternative therapies or supportive care; and the Company’s development plans, regulatory pathway, and potential applications of the Hemopurifier. The foregoing list of risks and uncertainties is illustrative but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2025, and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances. Breakthrough Device designation expedites interaction with FDA but does not represent FDA clearance or approval and does not, by itself, establish safety or effectiveness. The findings described herein are preliminary in nature, have not been peer-reviewed, and may not be replicated in subsequent studies or clinical trials. Additional data would be required to assess safety and effectiveness.

 

Company Contact:
Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com  

 

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com  

 

Aethlon Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com

 

More info on AEMD at Investorideas.com Visit: https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Aethlon Medical, Inc. (AEMD) is a paid featured medical tech stock on Investor ideas More disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

 

 Research biotech stocks at Investorideas.com

https://www.investorideas.com/Companies/RenewableEnergy/stock_list.asp

 

 

 

 

About Investorideas.com – Where you find the best investing ideas

Investorideas.com is a trusted platform for retail investors, serving as a hub for innovative investing ideas for over 25 years. Known for its pioneering coverage of sectors like mining, cleantech, defense, and water stocks, the company and its executives have been featured in high-profile media outlets for its expertise. Investorideas.com is always at the forefront of investment trends, offering coverage of diverse industries such as Al, mining, and tech. With a mission to empower investors, the company provides breaking news, sector-focused articles, podcasts, and exclusive interviews with leading experts. In addition, its award-winning branded content, Al-driven short videos, and podcasts highlight key investing insights and feature prominent industry leaders.

 

Why partner with Investor Ideas? Discover our powerful news, PR, social media, and podcast solutions for crypto stocks at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Why should companies choose Investor Ideas for digital advertising and guest posts?

https://www.investorideas.com/Advertise/

 

Follow us on X @investorideas @stocknewsbites

Follow us on Facebook https://www.facebook.com/Investorideas

Follow Investorideas and the Exploring Mining Podcast on YouTube https://www.youtube.com/c/Investorideas

 

Investors stay ahead by signing up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Join our free Telegram community

https://t.me/+o8DxSAgeNCk2ZGVh

 

Contact us for more info  

Call 800 665 0411

 

 

 

 

 

VisionWave Holdings ( $VWAV) Positions for Defense Dominance: Private Varan UGV Showcase Alongside Battle-Proven Drone Fleet at Eurosatory 2026; @VWAVInc

 

VisionWave Holdings ( $VWAV) Positions for Defense Dominance: Private Varan UGV Showcase Alongside Battle-Proven Drone Fleet at Eurosatory 2026; @VWAVInc

 

 

 

Investorideas.com, a top rated investment site for retail Investors following AI and defense stocks, reports on breaking news and trading for VisionWave Holdings, Inc (Nasdaq: VWAV), a global developer of autonomous unmanned systems and AI-powered perception software.

VisionWave Holdings, Inc (Nasdaq: VWAV) announced it will present the Varan Unmanned Ground Vehicle (UGV) at an invitation-only private showcase in Paris coinciding with Eurosatory 2026.

The Varan preview will be held at a dedicated VisionWave facility near the exhibition venue across three days: Monday through Wednesday, June 15–17, 2026 exclusively for invited defense partners, government delegations, and institutional attendees. The company's Executive Chairman and CEO, Douglas Davis, will personally host each session alongside VisionWave's senior program team and Board members.

 

Paid News Dissemination on behalf of VWAV 

 

Read this news, featuring VWAV in full at https://www.investorideas.com/CO/VWAV/news/2026/05191-visionwave-vwav-varan-ugv-eurosatory.asp

 

World Preview

The Varan UGV: A Ground Platform Built from Zero

Varan is VisionWave's modular autonomous ground vehicle, developed entirely in-house from the ground up and being unveiled publicly for the first time at these events. Engineered around the principle that the payload defines the mission and the platform is the carrier, Varan is designed to replace entire fleets of single-purpose systems with a single, field-configurable robotics platform.

The platforms open mechanical, electrical, and software architecture is designed to enable operators to swap interchangeable mission payloads ranging from reconnaissance and surveillance suites to manipulator arms, IED detection systems, and tactical kinetic modules directly in the field, without modification to the underlying vehicle.

 

Key Specifications (subject to ongoing development and testing)

Varan: Technical Overview

•       SMET-class modular ground platform at a target price point of $100,000

•       All-terrain mobility on airless tires with articulated independent suspension

•       Height-adjustable chassis; lightweight and compact for ruggedized transport case shipment

•       Fully autonomous operation including GNSS-denied environments

•       Built-in IED detection; Counter-UAS enabled; virgin-territory mapping

•       Open API; field-serviceable; interoperable with VisionWave's aerial and sensing systems

•       Multi-mission capable: reconnaissance, perimeter security, infrastructure inspection, logistics resupply, and CBRN-tolerant operations

For a visual overview of the platform, please see the Varan product rendering: Varan UGV — Product Rendering Video

 

CEO Statement

Statement from Doug Davis, Executive Chairman and CEO

“Varan represents the culmination of everything VisionWave has built. We developed this platform from zero every mechanical system, every software layer, every design decision with one purpose: to give defense operators a single autonomous platform with the goal of adapting to any mission in the field. Eurosatory brings together the people who matter most to us the decision-makers, the operators, and the program managers who are shaping the future of autonomous ground systems. We wanted to put the actual platform in front of them, in person, and let it speak for itself.”

 

Tactical Aerial Systems

Battle-Proven Drone Fleet: Deployed at the FIFA World Cup

The Paris showcase will also feature the VisionWave tactical aerial fleet. The fleet combines high-speed interceptor drones, extended-endurance ISR platforms, and loitering munitions, all operated under a single unified mission-command interface capable of managing up to 255 assets simultaneously.

 

Highlighted Platforms

•       MAD LB Standard: Multi-role heavy-lift ISR and transport; 3 kg payload; up to 78 minutes flight time; 10 m/s wind resistance

•       MAD MB: Compact canister-launched ISR; 1 kg payload; up to 80 minutes flight time; multiple launch modes including hand, tube, ground, and air-launch; 3,000 m service ceiling

•       MAD LB Heavy Lift: Extended-endurance configuration; 5 kg payload; up to 78 minutes flight time; designed for persistent ISR and austere-environment transport

•       Mission Command Software: Unified planning, swarm coordination, dock management, live simulation, and flight analytics across the full fleet

 

Perception Layer

Foresight 3D Sensing: Stealth Autonomy for the Modern Battlefield

Completing VisionWave's integrated system stack is the Foresight 3D Sensing software: a passive, non-emitting stereo-vision perception layer that transforms standard visible-light and thermal-infrared cameras into a high-resolution dense 3D point cloud. Foresight seeks to enable autonomous navigation and all-object detection across zero-visibility environments — sandstorms, fog, degraded lighting without emitting any electromagnetic signature detectable by adversary systems.

Integrated with both the Varan UGV and the tactical drone fleet, Foresight closes the perception loop for fully autonomous mission execution across denied, degraded, and electronically contested environments.

 

Event Details

Private Preview: By Invitation Only

•       Dates: Monday, June 15 through Wednesday, June 17, 2026

•       Location: Paris, France (precise venue shared upon RSVP confirmation)

•       Format: Closed-door partner sessions of 45–60 minutes; walkaround access, technical briefing, and direct Q&A with VisionWave's engineering team and management

•       Time slots: Pre-exhibition breakfast sessions (7:30–9:30 AM) and post-exhibition sessions (5:00–7:30 PM)

•       Transportation provided between the Eurosatory venue and the VisionWave facility

•       NDA required for technical deep-dive sessions

•       RSVP: varan@vwav.inc — please include names, titles, and two preferred time slots

 

 

Important Notice

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, without limitation, statements relating to the planned private showcase event at Eurosatory 2026, the Varan Unmanned Ground Vehicle (UGV) and its intended capabilities and applications, the tactical drone fleet and its potential deployments, the Foresight 3D Sensing software, product development and integration activities, and other business and strategic initiatives.

These statements are based on the Company’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated. Forward-looking statements are generally identified by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” and similar expressions, or by statements that events, trends or results “may,” “will,” or “could” occur or be achieved.

Such forward-looking statements include, without limitation, statements regarding the timing, location and format of the private preview event, the technical specifications and operational capabilities of the Varan UGV, the deployment or demonstration of tactical aerial systems, the performance characteristics of Foresight 3D Sensing software, and the Company’s ability to successfully develop, integrate, and commercialize its autonomous systems platforms.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including but not limited to: development, integration, and testing risks inherent in advanced autonomous systems and AI-powered technologies; regulatory, export control, and national security approval requirements (including ITAR and related regimes); market acceptance and the competitive landscape for unmanned ground and aerial systems; the availability of financing and capital resources; macroeconomic and geopolitical conditions (including ongoing conflicts and regional instability); risks associated with government and defense contracting; intellectual property protection and enforcement; integration risks related to recently acquired technologies and subsidiaries (including Solar Drone and xCalibre™ assets); delays or failures in achieving development milestones; dependence on key personnel and strategic partners; and other risks and uncertainties described in the Company’s filings with the U.S. Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release and in the Company’s SEC filings. VisionWave undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Investors are cautioned not to place undue reliance on these forward-looking statements.

About VisionWave Holdings, Inc.

VisionWave Holdings, Inc. (Nasdaq: VWAV) is a defense and advanced sensing technology company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave's mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and fixed-site environments. The Company’s website is https://www.vwav.inc/.

Investor Contact: investors@vwav.inc • Website: www.vwav.inc

 

Watch recent VWAV video

https://www.youtube.com/shorts/wr4R7VSy7VM

VisionWave Holdings is a Featured Defense stock on Investorideaas.om

https://www.investorideas.com/CO/VWAV/

Research more defense stocks at Investorideas stock directory

https://www.investorideas.com/Companies/HomelandDefense/stock_list.asp

Disclaimer/Disclosure: VisionWave Holdings, Inc. is a paid for featured defense company on Investorideas.com. Investorideas is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. Contact management and IR of each company directly regarding specific questions. More disclaimer info:  Learn more about publishing your news release and our other news services on the Investorideas.com newswire. Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:  https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com - Where you find the best investing ideas

Investorideas.com is a trusted platform for retail investors, serving as a hub for innovative investing ideas for over 25 years. Known for its pioneering coverage of sectors like mining, cleantech, defense, and water stocks, the company and its executives have been featured in high-profile media outlets for its expertise. Investorideas.com is always at the forefront of investment trends, offering coverage of diverse industries such as Al, mining, and tech. With a mission to empower investors, the company provides breaking news, sector-focused articles, podcasts, and exclusive interviews with leading experts. In addition, its award-winning branded content, Al-driven short videos, and podcasts highlight key investing insights and feature prominent industry leaders.

 

Advertising agencies -Learn more about digital advertising and guest posts at Investorideas

https://www.investorideas.com/Advertise/

Follow & Contact

Follow us on X: @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube @Investorideas

 

Why Smart Money Is Meeting Defense Tech Stock VisionWave Holdings ( $VWAV) at Mar-a-Lago; @VWAVInc

 

 

 

Investorideas.com, a top rated investment site for retail Investors following AI and defense stocks, reports on breaking news and trading for VisionWave Holdings, Inc (Nasdaq: VWAV).

 

VisionWave Holdings, Inc (Nasdaq: VWAV) is a defense and advanced sensing technology company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave's mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and fixed-site environments.

 

VisionWave today announced that it will host two private investor events in Palm Beach, Florida on Wednesday, May 13, 2026 and Thursday, May 14, 2026.

 

CEO Doug Davis to Present at Private Luncheon at President Trump’s home at Mar-a-Lago Beach Club and Invitation-Only Dinner at BiCE Ristorante Palm Beach on May 13 – 14, 2026

 

The Company will host an investor dinner at BiCE Ristorante Palm Beach followed by an investor luncheon at Mar-a-Lago Beach Club in Palm Beach the next day. Both events are private and attendance is by invitation only.

 

The events are expected to include accredited investors, family offices, strategic advisors, business leaders, government officials and invited guests from the finance and media sectors. Senior management of VisionWave will provide updates regarding the Company's strategic initiatives, growth opportunities, and long-term business objectives.

 

Paid News Dissemination on behalf of VWAV 

 

Read this news, featuring VWAV in full at https://www.investorideas.com/CO/VWAV/news/2026/05111-visionwave-mar-a-lago-investor-events.asp

 

 “We look forward to engaging with shareholders and prospective investors in an intimate setting to discuss the Company’s vision, operational progress, and future opportunities in the defense sector.” said Doug Davis, Chief Executive Officer of VisionWave

 

About Vision Wave Holdings, Inc.

VisionWave Holdings, Inc. (Nasdaq: VWAV) is a defense and advanced sensing technology company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave's mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and fixed-site environments. The Company’s website is https://www.vwav.inc/.

 

Important Notice

This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation regarding any securities of Vision Wave Holdings, Inc. The investor events described herein are private, invitation-only, and restricted to accredited investors and invited guests. Participation in such events does not constitute an offer or sale of securities. Participation in such events does not constitute an offer or sale of securities, nor does it create any obligation or expectation of future investment opportunities. Any future offering of securities by Vision Wave, if made, will be conducted solely in compliance with applicable federal and state securities laws, including the Securities Act of 1933, as amended.

 

The events will be held at commercial venues and private club facilities. References to Mar-a-Lago Beach Club are made solely to identify the location and do not imply any endorsement by, or affiliation with, any political figure or organization.

 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding future operations, growth initiatives, investor engagement activities, and strategic plans including the timing and success of technology integrations. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including changes in market conditions, competition, regulatory developments, technology integration risks, intellectual property matters, and other risks described in the Company’s filings with the U.S. Securities and Exchange Commission. Vision Wave undertakes no obligation to publicly update or revise any forward-looking statements except as required by applicable law.

 

Investor Contact: investors@vwav.inc • Website: www.vwav.inc

 

Watch recent VWAV video

https://www.youtube.com/shorts/wr4R7VSy7VM

 

VisionWave Holdings is a Featured Defense stock on Investorideaas.om

https://www.investorideas.com/CO/VWAV/

 

Research more defense stocks at Investorideas stock directory

https://www.investorideas.com/Companies/HomelandDefense/stock_list.asp

 

Disclaimer/Disclosure: VisionWave Holdings, Inc. is a paid for featured defense company on Investorideas.com. Investorideas is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. Contact management and IR of each company directly regarding specific questions.
More disclaimer info:  Learn more about publishing your news release and our other news services on the Investorideas.com newswire. Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:  https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com - Where you find the best investing ideas

Investorideas.com is a trusted platform for retail investors, serving as a hub for innovative investing ideas for over 25 years. Known for its pioneering coverage of sectors like mining, cleantech, defense, and water stocks, the company and its executives have been featured in high-profile media outlets for its expertise. Investorideas.com is always at the forefront of investment trends, offering coverage of diverse industries such as Al, mining, and tech. With a mission to empower investors, the company provides breaking news, sector-focused articles, podcasts, and exclusive interviews with leading experts. In addition, its award-winning branded content, Al-driven short videos, and podcasts highlight key investing insights and feature prominent industry leaders.

 

Advertising agencies -Learn more about digital advertising and guest posts at Investorideas

https://www.investorideas.com/Advertise/

 

Follow & Contact

Follow us on X: @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube @Investorideas